News
PFE
--
0.00%
--
U.S. administers 345.6 mln doses of COVID-19 vaccines - CDC
reuters.com · 3h ago
BRIEF-U.S. CDC Says Delivered 400,675,525 Doses Of COVID-19 Vaccine As Of July 31
reuters.com · 4h ago
Vaccine Mandates Could Be Good News for Vaccine Makers
The protection from vaccinations may start to taper after several months, boosting the case for booster shots. Covid vaccine sales are looking like a long-term business for Pfizer, BioNTech, Moderna, and other producers.
Barrons.com · 7h ago
Covid Has Boosted the Healthcare Sector. Pfizer Stock Is a Prime Example.
With the Delta variant of coronavirus shaking things up, the healthcare sector has started gaining momentum.
Barrons.com · 23h ago
Pfizer Inc. stock outperforms competitors on strong trading day
marketwatch.com · 1d ago
FDA to speed up review for full approval of Pfizer/ BIoNTEch COVID-19 shot - Stat
The Food and Drug Administration expects to accelerate the review process of the COVID-19 vaccine developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), Stat News reported citing a senior FDA official. To speed up
Seekingalpha · 1d ago
FDA Puts All Hands on Deck to Review Pfizer-BioNTech Covid Shot
Bloomberg · 1d ago
Bowling Portfolio Management LLC Buys Utilities Select Sector SPDR ETF, UnitedHealth Group Inc, ...
GuruFocus News · 1d ago
UPDATE 1-Most COVID-19 cases in Massachusetts outbreak among vaccinated, says CDC
reuters.com · 1d ago
BRIEF-FDA, Under Pressure, Plans To Accelerate Review Of Pfizer’s Covid-19 Vaccine For Full Approval - Stat News
reuters.com · 1d ago
Fully vaccinated people made up 74% of cases in a COVID-19 outbreak in Massachusetts - CDC
On Friday, the Centers for Disease Control and Prevention (CDC) released data supporting the view that the COVID-19 Delta variant can cause infections even among fully vaccinated people. The CDC
Seekingalpha · 1d ago
BRIEF-U.S. CDC Says Delivered 399,090,105 Doses Of Covid-19 Vaccine As Of July 30
reuters.com · 1d ago
UPDATE 1-U.S. approval of COVID-19 shots could boost vaccination numbers, Fauci says
reuters.com · 1d ago
WHO expert: Delta variant poses stark choice between behavior change or 'more lockdowns'
The CDC's internal documents shed more light on the dangers of the Delta variant.
Yahoo Finance · 1d ago
Corcept's (CORT) Q2 Earnings Beat Estimates, Revenues Rise Y/Y
Zacks.com · 1d ago
Fauci hopes U.S. regulators fully approve COVID-19 shots by mid-August
reuters.com · 1d ago
Ocular Inflammation Treatment Market Industry Size, Competition, Trends and Growth Opportunities by Region 2021-2028
The is expected to exceed more than US$ 500 Billion by 2024 at a CAGR of 6% in the given forecast period.
Heraldkeepers · 1d ago
15 Most Valuable Biotech Companies in the World
In this article we will take a look at the 15 most valuable biotech companies in the world. You can skip our detailed analysis of the biotechnology industry’s outlook for 2021, and some of the major growth catalysts for biotech stocks, and go directly to t...
Insider Monkey · 1d ago
Botswana pays equivalent of $15 a dose for Sinovac's COVID-19 vaccine
reuters.com · 1d ago
UPDATE 1-COVID vaccine protection highly likely to wane over time - UK advisers say
reuters.com · 1d ago
Webull provides a variety of real-time PFE stock news. You can receive the latest news about Pfizer through multiple platforms. This information may help you make smarter investment decisions.
About PFE
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.